GRIPonMASH screens first patient and reports strong first-year results
Breaking milestones reached in project aiming to improve prevention and care of Metabolic dysfunction-Associated SteatoHepatitis (MASH).

About GRIPonMASH
GRIPonMASH will address the unmet public health need of reducing disease burden and comorbidities associated with Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD).
GRIPonMASH is a consortium founded by Julius Clinical and the University Medical Center Utrecht consisting of 27 involved parties dedicated to bring about a transformational change in the detection and diagnosis of MASH patients. The four year project is funded by the Innovative Health Initiative Joint Undertaking (IHI) which is funded jointly by the European Union (represented by the European Commission) and the life science industries (represented by COCIR, EFPIA / Vaccines Europe, EuropaBio, MedTech Europe). The aim is to achieve better information, diagnosis and lifestyle advice on MASH.
Our goal is to increase the number of people diagnosed and aware of the lifestyle changes needed and decrease the number of people with MASH and liver cancer.
The project is coordinated by the UMC Utrecht in the Netherlands.
Work Package Structure and WP leaders
- Academisch Medisch Centrum Amsterdam (AUMC) – Onno Holleboom
- Echosens – Francesca Braga
- Julius Clinical – Manuel Castro Cabezas & Vivian de Jong
- Echosens – Céline Fournier
- Universita Cattolica Del Sacro Cuore (UCSC) – Luca Miele
- Consiglio Nazionale delle Ricerche – Amalia Gastadelli
- Julius Clinical – Caterina Buranelli
- Servicio Andaluz De Salud (SAS) – Manuel Romero Gomez
- Fundación para la Gestión de la Investigación en Salud de Sevilla – Douglas Maya Miles
- Metadeq Limited – Aldo Trylesinski
- Universitair Medisch Centrum Utrecht (UMCU) – Sara Beigrezaei
- Charokopeio Panepistimio – George Dedousis
- Charokopeio Panepistimio – Evelina Mentsiou-Nikolaou
- Universitair Ziekenhuis Antwerpen (UZA) – Sven Franque
- Universitair Medisch Centrum Utrecht (UMCU) – Ghislaine Van Thiel
- Elevate Health – Daan van der Ham
- European Liver Patients Association (ELPA) – Marko Korenjak
- Universitair Medisch Centrum Utrecht (UMCU) – Oscar H. Franco
- Echosens – Jo Massoels
10 Enrolling Countries & Pls
Each of the 10 enrolling countries will contribute with 1000 subjects, ensuring a robust and diverse dataset. Logistics and coordination are meticulously managed by the Centre of Excellence (CoE), with recruitment efforts seamlessly conducted at Primary Care Practices (PCP) and clinics.
- The Netherlands
- Belgium
- Germany
- France
- Portugal
- Spain
- Italy
- Czech Republic
- Romania
- Greece





























